Investigation of the Effects of Frailty and Sarcopenia on Postoperative Recovery and Complications in Geriatric Patients

March 24, 2025 updated by: Ferda YAMAN, Eskisehir Osmangazi University

Investigation of the Effects of Frailty and Sarcopenia on Postoperative Recovery and Complications in Geriatric Patients Undergoing Colorectal Cancer Surgery

After obtaining ethical approval, 42 patients with American Society of Anesthesiologists (ASA) scores I-III who were scheduled for surgery under general anesthesia were included in our prospective study. Patients were monitored in the preoperative preparation room in the operating room and frailty was assessed using the FRAIL scale and sarcopenia was assessed using the STAR ratio. The thickness of the rectus femoris and vastus intermedius muscles of the patients was measured and recorded by ultrasonography. Thigh lengths were measured and recorded. Rectus Femoris/Thigh Length (RF/B), Vastus Intermedius/Thigh Length (VI/B), and Total Muscle Thickness/Thigh Length (T/B) were calculated and recorded. Patients were followed up according to the Modified Aldrete Score after surgery in the anesthesia recovery unit, and the time to reach 9-10 points was recorded, and the time to leave the recovery unit was recorded. Postoperatively, complications were followed up according to the Clavien-Dindo Classification, and discharge times from the hospital were recorded.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Frailty is a clinically identifiable state of heightened vulnerability resulting from age-related declines in physiological systems and functions, leading to impaired resilience to stressors. Frailty is highly prevalent among the elderly and is associated with an increased risk of falls, disability, hospitalization, and mortality. Magnetic resonance imaging (MRI) and computed tomography (CT) are considered the gold standard for sarcopenia diagnosisCT is also limited due to radiation exposure and similar logistical constraints. In contrast, ultrasonography (USG) is portable, cost-effective, and can be performed at the bedside without radiation exposure.

Using high-frequency ultrasound probes, peripheral muscle tissues and their dimensions can be rapidly assessed.

Study Type

Observational

Enrollment (Actual)

42

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Odunpazarı
      • Eski̇şehi̇r, Odunpazarı, Turkey, 26040
        • University of Eskisehir Osmangazi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

42 patients over 60 years of age with ASA score I-III who were to undergo colorectal malignancy surgery under general anesthesia

Description

Inclusion Criteria:

  • patients over 60 years of age who are undergoing colorectal malignancy surgery under general anesthesia
  • patients willing to participate in the study
  • Patients with ASA score I-III

Exclusion Criteria:

  • Patients with Parkinson's disease,
  • Alzheimer's disease,
  • history of cerebrovascular events,
  • neuromuscular disease,
  • cognitive dysfunction,
  • severe liver disease,
  • severe heart disease,
  • impaired cooperation due to kidney disease,
  • emergency and trauma patients,
  • patients with bilateral lower extremity amputations

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
age
Time Frame: 1 year
years old
1 year
sex
Time Frame: 1 year
female, male
1 year
height
Time Frame: 1 year
meter
1 year
body weight
Time Frame: 1. year
kg
1. year
educational status
Time Frame: 1 year
primary school graduate, middle school graduate, high school graduate, university graduate
1 year
marital status
Time Frame: 1 year
married, single, widowed
1 year
rectus femoris muscle thickness
Time Frame: 1 year
cm
1 year
vastus intermedius(VI) thickness
Time Frame: 1 year
cm
1 year
rectus femoris-to-thigh length ratio
Time Frame: 1 year
ratio
1 year
vastus intermedius-thigh length ratio
Time Frame: 1 year
ratio
1 year
total muscle thickness to thigh length ratio
Time Frame: 1 year
ratio
1 year
frailty score
Time Frame: 1 year
0-NORMAL, 1-2 PRE-FRAİL, 3-5 FRAİL
1 year
recovery time from anesthesia
Time Frame: 1 year
minutes
1 year
hospital discharge time
Time Frame: 1 year
days
1 year
Modified Clavien-Dindo Classification
Time Frame: 1 year
1, 2, 3A, 3B, 4A, 4B, 5
1 year
ASA score
Time Frame: 1 year
American Society of Anesthesiologists' Classification (ASA 1,2,3,4,5)
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: ferda yaman, Assoc prof, University of Eskisehir Osmangazi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 20, 2023

Primary Completion (Actual)

July 20, 2024

Study Completion (Actual)

July 20, 2024

Study Registration Dates

First Submitted

March 17, 2025

First Submitted That Met QC Criteria

March 17, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 27, 2025

Last Update Submitted That Met QC Criteria

March 24, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frailty

Clinical Trials on ultrasonography

Subscribe